Since this phenomenon could be observed not only in malignant but also in premalignant and benign epithelial cells, one can speculate that the switch of Nrf2 from tumor suppressor to a tumor promoter might occur quite early in tumorigenesis and in particular in the concomitant presence of TGF-β1. This evidence concerns the gene TGFB1 and neoplasm.